173 related articles for article (PubMed ID: 23408392)
1. Distinct microRNA profiles are associated with the severity of hepatitis C virus recurrence and acute cellular rejection after liver transplantation.
Joshi D; Salehi S; Brereton H; Arno M; Quaglia A; Heaton N; O'Grady J; Agarwal K; Aluvihare V
Liver Transpl; 2013 Apr; 19(4):383-94. PubMed ID: 23408392
[TBL] [Abstract][Full Text] [Related]
2. Differential transcriptome patterns for acute cellular rejection in recipients with recurrent hepatitis C after liver transplantation.
Asaoka T; Kato T; Marubashi S; Dono K; Hama N; Takahashi H; Kobayashi S; Takeda Y; Takemasa I; Nagano H; Yoshida H; Ruiz P; Tzakis AG; Matsubara K; Monden M; Doki Y; Mori M
Liver Transpl; 2009 Dec; 15(12):1738-49. PubMed ID: 19938108
[TBL] [Abstract][Full Text] [Related]
3. Differential allograft gene expression in acute cellular rejection and recurrence of hepatitis C after liver transplantation.
Sreekumar R; Rasmussen DL; Wiesner RH; Charlton MR
Liver Transpl; 2002 Sep; 8(9):814-21. PubMed ID: 12200784
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA signature at the time of clinical HCV recurrence associates with aggressive fibrosis progression post-liver transplantation.
Gehrau RC; Mas VR; Villamil FG; Dumur CI; Mehta NK; Suh JL; Maluf DG
Am J Transplant; 2013 Mar; 13(3):729-37. PubMed ID: 23312020
[TBL] [Abstract][Full Text] [Related]
5. Molecular pathways differentiate hepatitis C virus (HCV) recurrence from acute cellular rejection in HCV liver recipients.
Gehrau R; Maluf D; Archer K; Stravitz R; Suh J; Le N; Mas V
Mol Med; 2011; 17(7-8):824-33. PubMed ID: 21519635
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C pathogenesis and outcomes after liver transplantation: probing microRNA expression for new insights.
Bowen DG; Shackel NA
Liver Transpl; 2013 Apr; 19(4):355-7. PubMed ID: 23447337
[No Abstract] [Full Text] [Related]
7. Transforming growth factor β1 polymorphisms and progression of graft fibrosis after liver transplantation for hepatitis C virus--induced liver disease.
Eurich D; Bahra M; Boas-Knoop S; Lock JF; Golembus J; Neuhaus R; Neuhaus P; Neumann UP
Liver Transpl; 2011 Mar; 17(3):279-88. PubMed ID: 21384510
[TBL] [Abstract][Full Text] [Related]
8. Relationship between the interleukin-28b gene polymorphism and the histological severity of hepatitis C virus-induced graft inflammation and the response to antiviral therapy after liver transplantation.
Eurich D; Boas-Knoop S; Ruehl M; Schulz M; Carrillo ED; Berg T; Neuhaus R; Neuhaus P; Neumann UP; Bahra M
Liver Transpl; 2011 Mar; 17(3):289-98. PubMed ID: 21384511
[TBL] [Abstract][Full Text] [Related]
9. Hepatic steatosis at 1 year is an additional predictor of subsequent fibrosis severity in liver transplant recipients with recurrent hepatitis C virus.
Brandman D; Pingitore A; Lai JC; Roberts JP; Ferrell L; Bass NM; Terrault NA
Liver Transpl; 2011 Dec; 17(12):1380-6. PubMed ID: 21770018
[TBL] [Abstract][Full Text] [Related]
10. Liver transplant complications in hepatitis C infected recipients: recurrence versus rejection.
Gehrau RC; Mas VR; Suh JL; Maluf DG
Expert Rev Gastroenterol Hepatol; 2014 Jul; 8(5):453-6. PubMed ID: 24641719
[TBL] [Abstract][Full Text] [Related]
11. Post-liver transplant hepatitis C virus recurrence: an unresolved thorny problem.
Grassi A; Ballardini G
World J Gastroenterol; 2014 Aug; 20(32):11095-115. PubMed ID: 25170198
[TBL] [Abstract][Full Text] [Related]
12. Minichromosome maintenance protein-2-positive portal tract lymphocytes distinguish acute cellular rejection from hepatitis C virus recurrence after liver transplantation.
Unitt E; Gelson W; Davies SE; Coleman N; Alexander GJ
Liver Transpl; 2009 Mar; 15(3):306-12. PubMed ID: 19243005
[TBL] [Abstract][Full Text] [Related]
13. YKL-40-gene polymorphism affects acute cellular rejection and fibrosis progression after transplantation for hepatitis C virus-induced liver disease.
Eurich D; Neumann UP; Boas-Knoop S; Neuhaus R; Kiessling A; Yahyazadeh A; Trautwein C; Wasmuth H; Puhl G; Neuhaus P; Bahra M
J Gastroenterol Hepatol; 2013 Jan; 28(1):153-60. PubMed ID: 22989351
[TBL] [Abstract][Full Text] [Related]
14. Digital image analysis of collagen assessment of progression of fibrosis in recurrent HCV after liver transplantation.
Manousou P; Burroughs AK; Tsochatzis E; Isgro G; Hall A; Green A; Calvaruso V; Ma GL; Gale J; Burgess G; O'Beirne J; Patch D; Thorburn D; Leandro G; Dhillon AP
J Hepatol; 2013 May; 58(5):962-8. PubMed ID: 23262247
[TBL] [Abstract][Full Text] [Related]
15. Tissue hepatitis C virus RNA quantification and protein expression help identify early hepatitis C virus recurrence after liver transplantation.
D'Errico-Grigioni A; Fiorentino M; Vasuri F; Gruppioni E; Fabbrizio B; Zucchini N; Ballardini G; Morelli C; Pinna AD; Grigioni WF
Liver Transpl; 2008 Mar; 14(3):313-20. PubMed ID: 18306349
[TBL] [Abstract][Full Text] [Related]
16. Outcome of recurrent hepatitis C virus after liver transplantation in a randomized trial of tacrolimus monotherapy versus triple therapy.
Manousou P; Samonakis D; Cholongitas E; Patch D; O'Beirne J; Dhillon AP; Rolles K; McCormick A; Hayes P; Burroughs AK
Liver Transpl; 2009 Dec; 15(12):1783-91. PubMed ID: 19938143
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C recurrence is not adversely affected by the use of donation after cardiac death liver allografts.
Tao R; Ruppert K; Cruz RJ; Malik SM; Shaikh O; Ahmad J; DiMartini A; Humar A; Fontes PA; de Vera ME
Liver Transpl; 2010 Nov; 16(11):1288-95. PubMed ID: 21031544
[TBL] [Abstract][Full Text] [Related]
18. Impact of immunosuppression minimization and withdrawal in long-term hepatitis C virus liver transplant recipients.
Manzia TM; Angelico R; Ciano P; Mugweru J; Owusu K; Sforza D; Toti L; Tisone G
World J Gastroenterol; 2014 Sep; 20(34):12217-25. PubMed ID: 25232255
[TBL] [Abstract][Full Text] [Related]
19. The Role of Monocyte/Macrophage and CXCR3 in Differentiation between Recurrent Hepatitis C and Acute Cellular Rejection Postliver Transplantation.
Gomaa AI; Ehsan NA; Elrefaei AA; Sultan MM; Elsabaawy MM
J Immunol Res; 2018; 2018():2726939. PubMed ID: 29854831
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin blockade does not affect fibrosis progression in recurrent hepatitis C after liver transplantation.
Guillaud O; Gurram KC; Puglia M; Lilly L; Adeyi O; Renner EL; Selzner N
Transplant Proc; 2013; 45(6):2331-6. PubMed ID: 23953545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
